Export

EN
FR
Prostaglandin E1
Essential medicine status
Section:
22. Medicines for reproductive health and perinatal care 22.6. Medicines administered to the neonate [c]
ATC codes: C01EA01
EMLc
Indication
Other specified congenital anomaly of great arteries including arterial duct ICD11 code: LA8C.Y
INN
Alprostadil
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 0.5 mg per mL in alcohol (EMLc)
EML status history
First added in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Sex
All
Age
Newborn (< 1 month)
Therapeutic alternatives
prostaglandin E2 (ATC codes: G02AD02)
Parenteral > General injections > IV: 1 mg per mL
Patent information
Patents have expired in most jurisdictions
Wikipedia
Prostaglandin E1
DrugBank
Prostaglandin e (Alprostadil)
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended to retain the square box for prostaglandin E, but assign it to prostaglandin E1, and specify prostaglandin E2 as an alternative on the EMLc for this indication.